Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Brennscheidt

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Cytokines in clinical cancer treatment trials: methodological aspectsU Brennscheidt, A Lindemann
Arzneimittel-Forschung|January 10, 2001
Pharmacokinetics of nortilidine and naloxone after administration of tilidine/naloxone solution or tilidine/naloxone sustained release tabletsU Brennscheidt, K U Seiler, P Thomann
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Interleukin-10 and phenomena of tolerance in interleukin-2 therapyM Engelhardt, U Brennscheidt, R Mertelsmann, et al.
Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1984
Palmar fibromatosis (Dupuytren's contracture). Ultrastructural and enzyme histochemical studies of 43 casesH Iwasaki, H Müller, H J Stutte, et al.
Molecular Pharmacology|February 1, 1991
Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosineR Henschler, U Brennscheidt, R Mertelsmann, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
Clinical and immunomodulatory effects of repetitive 2-day cycles of high-dose continuous infusion IL-2M Engelhardt, K Wirth, R Mertelsmann, et al.
Critical Reviews in Oncogenesis|January 1, 1990
raf oncogenes in carcinogenesisS M Storm, U Brennscheidt, G Sithanandam, et al.
European Journal of Immunology|December 1, 1993
The mitogenic response of T cells to interleukin-2 requires Raf-1D Riedel, U Brennscheidt, M Kiehntopf, et al.
Journal of Clinical Pharmacology|January 6, 2001
Pharmacokinetics of tilidine in terminal renal failureK U Seiler, E Jähnchen, D Trenk, et al.
Alimentary Pharmacology & Therapeutics|November 14, 1997
Tilidine does not affect human sphincter of Oddi motility--a randomized, controlled studyT Wehrmann, D Rausch, K U Seiler, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Cytokines in clinical cancer treatment trials: methodological aspectsU Brennscheidt, A Lindemann
Arzneimittel-Forschung|January 10, 2001
Pharmacokinetics of nortilidine and naloxone after administration of tilidine/naloxone solution or tilidine/naloxone sustained release tabletsU Brennscheidt, K U Seiler, P Thomann
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Interleukin-10 and phenomena of tolerance in interleukin-2 therapyM Engelhardt, U Brennscheidt, R Mertelsmann, et al.
Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1984
Palmar fibromatosis (Dupuytren's contracture). Ultrastructural and enzyme histochemical studies of 43 casesH Iwasaki, H Müller, H J Stutte, et al.
Molecular Pharmacology|February 1, 1991
Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosineR Henschler, U Brennscheidt, R Mertelsmann, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
Clinical and immunomodulatory effects of repetitive 2-day cycles of high-dose continuous infusion IL-2M Engelhardt, K Wirth, R Mertelsmann, et al.
Critical Reviews in Oncogenesis|January 1, 1990
raf oncogenes in carcinogenesisS M Storm, U Brennscheidt, G Sithanandam, et al.
European Journal of Immunology|December 1, 1993
The mitogenic response of T cells to interleukin-2 requires Raf-1D Riedel, U Brennscheidt, M Kiehntopf, et al.
Journal of Clinical Pharmacology|January 6, 2001
Pharmacokinetics of tilidine in terminal renal failureK U Seiler, E Jähnchen, D Trenk, et al.
Alimentary Pharmacology & Therapeutics|November 14, 1997
Tilidine does not affect human sphincter of Oddi motility--a randomized, controlled studyT Wehrmann, D Rausch, K U Seiler, et al.
Pageof 3